Nurix Therapeutics Inc. (NRIX)
NASDAQ: NRIX
· Real-Time Price · USD
10.57
0.01 (0.09%)
At close: Aug 15, 2025, 3:59 PM
11.00
4.07%
After-hours: Aug 15, 2025, 05:17 PM EDT
Nurix Therapeutics Income Statement
Financials in USD. Fiscal
year is
December - November.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | May 31, 2025 | Feb 28, 2025 | Nov 30, 2024 | Aug 31, 2024 | May 31, 2024 | Feb 29, 2024 | Nov 30, 2023 | Aug 31, 2023 | May 31, 2023 | Feb 28, 2023 | Nov 30, 2022 | Aug 31, 2022 | May 31, 2022 | Feb 28, 2022 | Nov 30, 2021 | Aug 31, 2021 | May 31, 2021 | Feb 28, 2021 |
Revenue | 44.06M | 18.45M | 13.28M | 12.59M | 12.09M | 16.59M | 15.16M | 18.47M | 30.68M | 12.69M | 6.78M | 10.79M | 11.43M | 9.62M | 7.4M | 10.25M | 7.09M | 5.01M |
Cost of Revenue | n/a | 4.13M | n/a | 4.15M | 4.09M | 3.89M | 3.76M | 3.38M | 3.33M | 3.18M | 3.04M | 2.89M | 2.63M | 2.25M | 757K | 30.91M | 25.99M | 23M |
Gross Profit | n/a | 14.32M | 13.28M | 8.44M | 8M | 12.7M | 11.4M | 15.08M | 27.34M | 9.51M | 3.75M | 7.91M | 8.8M | 7.37M | 6.64M | -20.65M | -18.9M | -17.99M |
Operating Income | -48.32M | -62.86M | -64.66M | -54.61M | -48.54M | -45.22M | -45.33M | -40.01M | -26.77M | -42.95M | -48.69M | -46.72M | -45.72M | -42.32M | -37.95M | -29M | -26.41M | -24.52M |
Interest Income | n/a | 6.51M | 6.12M | 5.74M | 4.08M | 3.79M | 3.38M | 3.03M | 2.49M | 2.22M | 1.97M | 1.01M | 314K | 211K | 295K | 39K | 171K | 318K |
Pretax Income | -42.7M | -56.35M | -58.54M | -48.87M | -44.46M | -41.43M | -41.96M | -36.98M | -24.28M | -40.73M | -46.72M | -45.71M | -45.4M | -42.53M | -37.66M | -28.96M | -26.24M | -24.2M |
Net Income | -43.46M | -56.35M | -58.55M | -48.96M | -44.55M | -41.52M | -41.96M | -36.98M | -21.79M | -35.33M | -41.71M | -44.7M | -45.09M | -42.32M | -37.7M | -28.84M | -26.38M | -24.27M |
Selling & General & Admin | 14.28M | 11.65M | 10.72M | 11.72M | 9.95M | 9.96M | 8.96M | 10.62M | 11.68M | 9.82M | 9.37M | 9.75M | 9.65M | 9.23M | 8.82M | 8.34M | 7.51M | 6.53M |
Research & Development | 78.1M | 69.66M | 67.22M | 55.48M | 46.59M | 47.96M | 47.78M | 47.86M | 45.76M | 45.82M | 46.11M | 47.76M | 47.49M | 43.14M | 36.53M | 30.91M | 25.99M | 23M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 92.38M | 81.32M | 77.94M | 67.2M | 56.54M | 57.92M | 56.74M | 58.48M | 57.44M | 55.64M | 55.47M | 57.51M | 57.15M | 52.37M | 45.35M | 39.25M | 33.51M | 29.53M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | -1.76M | -1.84M | -1.82M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | n/a | 81.32M | 77.94M | 67.2M | 60.63M | 61.8M | 60.49M | 58.48M | 57.44M | 55.64M | 55.47M | 57.51M | 57.15M | 52.37M | 45.35M | 39.25M | 33.51M | 29.53M |
Income Tax Expense | 760K | n/a | 8K | 82K | 90K | 90K | n/a | n/a | -2.49M | -5.4M | -5.01M | -1.01M | -314K | -211K | 44K | -123K | 139K | 71K |
Shares Outstanding (Basic) | 83.88M | 83.56M | 78.41M | 72.78M | 62.38M | 54.9M | 54.67M | 54.39M | 54.26M | 54.03M | 53.94M | 50.87M | 44.9M | 44.69M | 44.55M | 44.37M | 43.8M | 38.78M |
Shares Outstanding (Diluted) | 83.88M | 83.56M | 78.41M | 72.78M | 62.38M | 54.9M | 54.67M | 54.39M | 54.26M | 54.03M | 53.94M | 50.87M | 44.9M | 44.69M | 44.55M | 44.37M | 43.8M | 38.78M |
EPS (Basic) | -0.52 | -0.67 | -0.75 | -0.67 | -0.71 | -0.76 | -0.77 | -0.68 | -0.4 | -0.65 | -0.77 | -0.88 | -1 | -0.95 | -0.85 | -0.65 | -0.6 | -0.63 |
EPS (Diluted) | -0.52 | -0.67 | -0.75 | -0.67 | -0.71 | -0.76 | -0.77 | -0.68 | -0.4 | -0.65 | -0.77 | -0.88 | -1 | -0.95 | -0.85 | -0.65 | -0.6 | -0.63 |
EBITDA | -48.32M | -58.74M | -60.35M | -50.47M | -44.45M | -41.33M | -41.58M | -36.63M | -23.43M | -39.77M | -45.65M | -42.82M | -42.77M | -40.49M | -37.2M | -28.25M | -25.64M | -23.88M |
EBIT | n/a | -62.86M | -64.66M | -54.61M | -48.54M | -45.22M | -45.33M | -40.01M | -26.77M | -42.95M | -48.69M | -46.72M | -45.72M | -42.74M | -37.95M | -29M | -26.41M | -24.52M |
Depreciation & Amortization | n/a | 4.13M | 4.3M | 4.15M | 4.09M | 3.89M | 3.76M | 3.38M | 3.33M | 3.18M | 3.04M | 2.89M | 2.63M | 2.25M | 757K | 700K | 600K | 643K |